Form 4: Aethlon Medical Director Angela Rossetti Acquires Shares Through Restricted Stock Units

Director Angela Rossetti acquired 142,857 shares of Aethlon Medical Inc. through restricted stock units (RSUs) at a price of $0.35 on April 23, 2025.

Summary

• Angela Rossetti, a director of Aethlon Medical Inc. (AEMD), reported a transaction on April 23, 2025.
• Rossetti acquired 142,857 shares of common stock through the grant of Restricted Stock Units (RSUs) at a price of $0.35.
• Following the transaction, Rossetti directly owns 343,400 shares of Aethlon Medical Inc.
• The RSUs vest in four equal quarterly installments starting June 30, 2025, and ending March 31, 2026, contingent upon continued service with the company.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The RSUs vest over a period of four quarters, contingent on the director's continued service with the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Aethlon Medical Inc, Angela Rossetti, Director, RSUs, Stock Acquisition, Beneficial Ownership, AEMD